Post-IPO Equity - Immunocore - Jul 18, 2022 Funding Round Profile - Cointime

Bitcoin $69,975.98 +3.13%
Ethereum $2,446.21 +0.73%
BNB $568.15 +2.71%
Optimism $1.42 +6.18%
Arbitrum $0.49 +2.71%
Solana $167.05 +4.60%
Polygon $0.30 +3.06%
Cosmos $4.18 +6.19%
Avalanche $24.16 +5.12%

Bitcoin $69,975.98 +3.13%
Ethereum $2,446.21 +0.73%
BNB $568.15 +2.71%
Optimism $1.42 +6.18%
Arbitrum $0.49 +2.71%
Solana $167.05 +4.60%
Polygon $0.30 +3.06%
Cosmos $4.18 +6.19%
Avalanche $24.16 +5.12%

Immunocore

company

Funding Round

Post-IPO Equity

Money Raised

$ 140M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
General Atlantic	-	-	-	Detail
Rock Springs Capital	-	-	-	Detail
RTW Investments	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 11, 2021	Series C	$ 75M	BlackRock	Detail
Jul 16, 2015	Series A	$ 320M	Eli Lilly,RTW Investments,etc.	Detail
Nov 5, 2012	Grant	£ 2.40M	Biomedical Catalyst Fund	Detail
Jan 11, 2021	Debt Financing	$ 100M	Oxford Finance LLC	Detail
Mar 2, 2020	Series B	$ 130M	Bill & Melinda Gates Foundation,CCB International,etc.	Detail
Sep 18, 2017	Series B	$ 40M	Bill & Melinda Gates Foundation	Detail
Feb 4, 2021	IPO	$ 258.31M		Detail